规范性天然导向解压改善了尿液反应:多中心ENACT-HF研究
Jeroen Dauw1,2, Kristina Charaya3, Małgorzata Lelonek4
1Ziekenhuis Oost-Limburg, Department of Cardiology, Genk, Belgium (J.D., P.N., M.D., P.M.).
Circulation. Heart failure
|January 5, 2024
概括
在急性心力衰竭中使用尿的标准化利尿剂协议显著增加了自然尿和利尿. 这种方法被证明是可行的,安全的,并减少了住院时间.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
背景情况:
- 建议在急性心力衰竭中对利尿剂的尿指导,但缺乏可靠的数据.
- ENACT-HF研究旨在通过调查标准化的自然尿路导导尿剂协议来弥补这一差距.
研究的目的:
- 评估在急性心力衰竭患者与体积过载的标准化尿导向性利尿剂方案的可行性和有效性.
- 为了比较这个协议与护理标准在自然尿,尿液和临床结果方面.
主要方法:
- 这是一项国际性的,多中心的,开放的,实用性的研究,将标准化利尿剂协议与标准护理进行比较.
- 该方案利用尿中的来指导利尿剂治疗.
- 主要终点:在1天后的自然化. 二级终点:累积性尿/尿,住院时间长,住院死亡率.
主要成果:
- 标准化方案手臂在第1天 (1.64比率,P<0.001) 和第2天 (1.52比率,P<0.001) 显示出显著更高的自然养.
- 在协议手臂中观察到较大的尿液 (1.33比率,P<0.001) 和较短的停留时间 (0.87比率,P=0.036).
- 住院死亡率在两组之间是相似的 (1.4%对2.0%,P=0.852).
结论:
- 一个标准化的自然尿导向的利尿剂方案是可行的和安全的,用于管理急性心力衰竭.
- 这种协议有效地提高了脱,导致自然尿和尿液的增加.
- 该协议还表明,住院时间的长度显著减少.
更多相关视频
相关概念视频
Heart Failure Drugs: Diuretics
388
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
388
Antihypertensive Drugs: Action of Diuretics
703
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
703
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
433
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
433
Upper Respiratory Drugs: Decongestants
230
Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
Most decongestants are readily available over-the-counter in...
230
Antihypertensive Drugs: Potassium-Sparing Diuretics
569
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
569
Antihypertensive Drugs: Vasodilators
528
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
528


